ID | 蛋白ID | Accession | GN:Name | DE:Name | GeneID |
271902 | NDBX_TITDI | C9X4J1 | | Anionic peptide; AP | 0 |
271901 | NDBX_MESMA | Q9Y0X5 | | Peptide BmKa1 {ECO:0000303|PubMed:15062994}; Acidic venom peptide Ka1 {ECO:0000303|PubMed:15062994}; BmK2; Non-disulfide-bridged peptide 6.1 {ECO:0000303|PubMed:16036557}; NDBP-6.1 {ECO:0000303|PubMed:16036557} | 0 |
271900 | NDBX_LYCMC | P0CJ16 | | Venom protein 49.1 | 0 |
271899 | NDBW_MESEU | E4VP50 | | Venom antimicrobial peptide-9; Meucin-18 {ECO:0000303|PubMed:19088182} | 0 |
271898 | NDBW2_LYCMC | P0CI92 | | Ponericin-W-like 32.2 | 0 |
271897 | NDBW1_LYCMC | P0CI91 | | Ponericin-W-like 32.1 | 0 |
271896 | NDBV_LYCMC | P0CJ06 | | Venom protein 37.1 | 0 |
271895 | NDBT_LYCMC | P0CJ19 | | Venom protein 27.7 | 0 |
271894 | NDBS_LYCMC | P0CI93 | | Bradykinin-potentiating peptide 25.12 {ECO:0000303|PubMed:20663230}; BPP-25.12 {ECO:0000303|PubMed:20663230} | 0 |
271893 | NDBR_LYCMC | P0CJ04 | | Venom protein 22.1 | 0 |
271892 | NDBQ_LYCMC | P0CI96 | | Anionic peptide 17.1 | 0 |
271891 | NDBP_LYCMC | D9U2B7 | | Bradykinin-potentiating peptide NDBP12 {ECO:0000303|PubMed:20663230}; BPP-12 {ECO:0000303|PubMed:20663230} | 0 |
271890 | NDBP8_TITSE | C0HJT2 | | Venom peptide 8 {ECO:0000303|PubMed:27221550} | 0 |
271889 | NDBO_LYCMC | P0CI97 | | Anionic peptide 10.1 | 0 |
271888 | NDBN_LYCMC | D9U2B6 | | Anionic peptide NDBP7 | 0 |
271887 | NDBM_LYCMC | D9U2B5 | | Bradykinin-potentiating peptide NDBP6; BPP-6 | 0 |
271886 | NDBL_LYCMC | P0CJ02 | | Venom protein 4.1 | 0 |
271885 | NDBK_LYCMC | P0CJ15 | | Venom protein 3.1 | 0 |
271884 | NDBH2_TITSE | P84190; P84192 | | Hypotensin-2 {ECO:0000305|PubMed:18445483}; Hypotensin II {ECO:0000303|PubMed:18445483}; TsHpt-II {ECO:0000303|PubMed:18445483}; Toxin Ts14 2 {ECO:0000303|PubMed:19689419}; Hypotensin IV {ECO:0000303|PubMed:18445483}; TsHpt-IV {ECO:0000303|PubMed:18445483}; Toxin Ts14 4 {ECO:0000303|PubMed:19689419} | 0 |
271883 | NDBH1_TITSE | A0A218QWX8; A0A218QWX9; P84189; P84191 | | Hypotensin-1 {ECO:0000305|PubMed:18445483}; Anti-hypertensive peptide {ECO:0000303|PubMed:27732900}; Hypotensin I {ECO:0000303|PubMed:18445483}; TsHpt-I {ECO:0000303|PubMed:18445483}; Tityustoxin-14 1 {ECO:0000305|PubMed:19689419}; Hypotensin toxin Ts14.1 {ECO:0000312|EMBL:QPD99051.1}; Ts14 1 {ECO:0000303|PubMed:19689419}; Hypotensin III {ECO:0000303|PubMed:18445483}; TsHpt-III {ECO:0000303|PubMed:18445483}; Toxin Ts14 3 {ECO:0000303|PubMed:19689419} | 0 |
271882 | NDBG2_LYCMC | P0CI95 | | Glycine-rich protein | 0 |
271881 | NDBG1_LYCMC | P0CI94 | | Glycine-rich protein | 0 |
271880 | NDBB_SYNY3 | P73735 | ndbB {ECO:0000303|PubMed:26023160} | Demethylphylloquinone reductase NdbB {ECO:0000303|PubMed:26023160}; 1.6.5.12 {ECO:0000269|PubMed:26023160} | 0 |
271879 | NDBAB_ARATH | Q94C12; Q9LS49 | | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10-B | 821370 |
271878 | NDBAA_ARATH | Q9M9B4 | | NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10-A | 841337 |
271877 | NDB52_MESEU | E4VP33; P0CH58 | | Meucin-25 {ECO:0000303|PubMed:20097251}; BeL-170 {ECO:0000303|PubMed:20097251}; Non-disulfide-bridged peptide 5.2 {ECO:0000303|PubMed:24184590}; NDBP-5.2 {ECO:0000303|PubMed:24184590} | 0 |
271876 | NDB51_MESEU | E4VNZ9; P0CH57 | | Potassium channel toxin MeuTXKbeta3-meucin-24 {ECO:0000303|PubMed:20889474}; Non-disulfide-bridged peptide 5.1 {ECO:0000303|PubMed:24184590}; NDBP-5.1 {ECO:0000303|PubMed:24184590} | 0 |
271875 | NDB4_UROYA | L0GCJ6 | | Putative antimicrobial peptide 7848; Uy7848 | 0 |
271874 | NDB4_PANCV | H2CYR5 | | Cytotoxic linear peptide | 0 |
271873 | NDB4_HOTJU | F1CJ89 | | Amphipathic peptide Hj0164 {ECO:0000303|PubMed:21329713} | 0 |
271872 | NDB4_HETSP | A0A0C4G4L1 | | Spiniferin {ECO:0000303|PubMed:24389272} | 0 |
271871 | NDB4_BUTOS | B8XH50 | | Amphipathic peptide Tx348 {ECO:0000303|Ref.1}; BoiTx348 {ECO:0000303|Ref.1} | 0 |
271870 | NDB4_ARATH | Q9SKT7 | NDB4 | External alternative NAD(P)H-ubiquinone oxidoreductase B4, mitochondrial; 1.6.5.9; External alternative NADH dehydrogenase NDB4; NADH:ubiquinone reductase (non-electrogenic) NDB4 | 816609 |
271869 | NDB4X_HETPE | P0DMF0 | | Peptide Hp1478 {ECO:0000303|PubMed:24315793} | 0 |
271868 | NDB4X_CHATC | P0DMF7 | | Peptide Ctri9594 {ECO:0000303|PubMed:23415044} | 0 |
271867 | NDB4W_HETPE | P0DME9 | | Peptide Hp1412 {ECO:0000303|PubMed:24315793} | 0 |
271866 | NDB4W_CHATY | P0DME5 | | Peptide Ctry2801 {ECO:0000303|PubMed:22791717} | 0 |
271865 | NDB4W_CHATC | P0DMF6 | | Peptide Ctri9293 {ECO:0000303|PubMed:23415044} | 0 |
271864 | NDB4V_TITSE | C0HJT3; P86828 | | Venom peptide 7.1 {ECO:0000303|PubMed:27221550}; Venom peptide 7 {ECO:0000303|PubMed:18718845} | 0 |
271863 | NDB4V_HETPE | P0DME8 | | Peptide Hp1239 {ECO:0000303|PubMed:24315793} | 0 |
271862 | NDB4V_CHATY | P0DMF4 | | Peptide Ctry2606 {ECO:0000303|PubMed:23415044} | 0 |
271861 | NDB4V_CHATC | P0DMF5 | | Peptide Ctri9194 {ECO:0000303|PubMed:23415044} | 0 |
271860 | NDB4U_TITSE | P86827 | | Venom peptide 6 {ECO:0000303|PubMed:18718845} | 0 |
271859 | NDB4U_TITCO | Q5G8B3 | | Putative antimicrobial peptide clone 6 | 0 |
271858 | NDB4U_MESMA | Q9GQW4 | | Peptide BmKn1 {ECO:0000303|PubMed:11463163}; Biologically active peptide 4; Non-disulfide-bridged peptide 5.1 {ECO:0000303|PubMed:16036557}; NDBP-5.1 {ECO:0000303|PubMed:16036557} | 0 |
271857 | NDB4U_LYCMC | P0CI89 | | Antimicrobial peptide 36.4 | 0 |
271856 | NDB4U_HETPE | P0DME7 | | Peptide Hp1165 {ECO:0000303|PubMed:24315793} | 0 |
271855 | NDB4U_CHATY | P0DMF3 | | Peptide Ctry2459 {ECO:0000303|PubMed:23415044} | 0 |
271854 | NDB4U_CHATC | P0DMF8 | | Peptide Ctri10261 {ECO:0000303|PubMed:23415044} | 0 |
271853 | NDB4T_TITSE | P86826 | | Venom peptide 3 {ECO:0000303|PubMed:18718845} | 0 |